Spinal muscular atrophy (SMA) is a recessive motor neuron disease that affects motor neurons in the anterior horn of the spinal cord. SMA results from the reduction of SMN (survival motor neuron) protein.
Introduction
Proximal spinal muscular atrophy (SMA) is an autosomal recessive degenerative disease characterized by selective loss of α motor neurons of the anterior horn of the spinal cord (Crawford and Pardo, 1996) . The loss of motor neurons results in atrophy of limb and trunk muscles. SMA has a different spectrum of clinical signs which can be roughly divided into three groups based on age of onset and clinical severity (Crawford and Pardo, 1996) . SMA results from the loss or mutation of the SMN1 (survival motor neuron 1) gene but retention of SMN2 (Lefebvre et al., 1995) . SMN is ubiquitously expressed and its expression is depressed in all SMA tissues including motor neurons (Coovert et al., 1997; Lefebvre et al., 1997) . In humans, the SMN gene is duplicated to yield two SMN genes (SMN1 and SMN2). SMN1 and SMN2 differ by a single nucleotide (C→T) within an exon splice enhancer of exon 7 (Lorson et al., 1999; Monani et al., 1999) . Transcripts derived from SMN1 contain exon 7 while most of the transcripts from SMN2 lack exon 7. The severity of the SMA phenotype depends on the copy number of SMN2 and the levels of SMN protein (Coovert et al., 1997; McAndrew et al., 1997; Lefebvre et al., 1997) .
SMN is required for the assembly of small nuclear ribonucleoproteins (snRNPs) which are essential for splicing of premessenger RNA transcripts (Liu and Dreyfuss, 1996) . snRNP biogenesis is defective in cell lines from SMA patients (Pellizzoni et al., 1999; Wan et al., 2005); Shpargel and Matera (2005) , however, demonstrated that some SMN mutants found in severe SMA patients have normal snRNP biogenesis. Furthermore, a recent study using a zebrafish model for Smn knockdown shows that there is a novel function in motor neuron axons that is independent of snRNP biogenesis (Carrel et al., 2006) . The mechanism which accounts for the motor neuron specificity of SMA is presently unclear.
Unlike humans, mice carry only one SMN gene (mSmn) which is equivalent to SMN1 (DiDonato et al., 1997; Viollet et al., 1997) . Loss of mSmn results in embryonic lethality in the mouse suggesting that the mSmn gene product is essential for cell function and survival (Schrank et al., 1997) . Conditional knockdown of mSmn in various cell types including neurons, differentiated myocytes and hepatocytes also leads to death of those cells (Cifuentes-Diaz et al., 2002; Nicole et al., 2003; Vitte et al., 2004) . Furthermore, reduction of SMN protein levels in zebrafish results in abnormalities in motor neuron-specific axon pathfinding (McWhorter et al., 2003) . In developing motor neurons with low SMN levels, axons are truncated and branch excessively. Insertion of SMN2 into mSmn null mice by transgenesis rescues the embryonic lethality phenotype (Monani et al., 2000) . Mice with low copy numbers (i.e., 1-2) of SMN2 develop severe (type I-like) SMA and die at 6-8 days (Monani et al., 2000; Hsieh-Li et al., 2000) while those mice with higher copy numbers (i.e., 8) of SMN2 are phenotypically normal when compared to nontransgenic
